Cerebral ischemia at early postoperative period of direct revascularization for moyamoya disease: a case report and literature review  

作　　者：Xiao-Lin Chen Li Ma Yu Chen Jun-Lin Lu Xun Ye Rong Wang Yuan-Li Zhao 

机构地区：[1]Department of Neurosurgery,Beijing Tiantan Hospital,Capital Medical University,Beijing100050,China [2]China National Clinical Research Center for Neurological Diseases,Beijing100050,China [3]Department of Neurosurgery,Peking University International Hospital,Peking University Health Science Center,Beijing102206,China [4]Center of Stroke,Beijing Institute for Brain Disorders,Beijing100050,China [5]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease,Beijing100050,China

出　　处：《Neuroimmunology and Neuroinflammation》2017年第3期46-53,共8页神经免疫与神经炎症（英文版）

基　　金：the Ministry of Science and Technology of China,National Key Technology Research and Development Program(2015BAI12B04,2013BAI09B03);Beijing Institute for Brain Disorders grant(BIBD-PXM2013_014226_07_000084);National Natural Science Foundation of China(H090681271313 and H090681571110 to Y.L.Zhao and 81500995 to X.L.Chen);China Scholarship Council(201508110252 to L.Ma).

摘　　要：Hypoperfusion and hyperperfusion could be causes of early postoperative complications that lead to neurological deterioration in patients with moyamoya diseases (MMD) after superficial temporal artery (STA) and middle cerebral artery (MCA) anastomosis. Here, the authors described a case of child-onset bilateral MMD that manifested transient cerebral ischemia in the contralateral hemisphere after left STA-MCA bypass in young adulthood. A new onset of cerebral ischemia in the contralateral hemisphere and transient neurological deterioration suggested the fragile hemodynamics of MMD during early perioperative period. Serial evaluation of postoperative cerebral hemodynamics and perfusion might facilitate targeted management in patients with unstable or advanced MMD.

关 键 词：MOYAMOYA disease CEREBRAL REVASCULARIZATION transient NEUROLOGICAL events PERIOPERATIVE management 

分 类 号：R73[医药卫生—肿瘤]